Eureka Therapeutics

About:

Eureka Therapeutics is a biotechnology company that develops T-cell therapies.

Website: https://www.eurekatherapeutics.com

Twitter/X: eurekathera

Top Investors: Lyell Immunopharma, Acorn Pacific Ventures, GP Capital, California Institute for Regenerative Medicine, Majuven

Description:

Eureka Therapeutics is a biotechnology company that focuses on immunotherapies for the treatment of cancer. They have developed E-ALPHA into one of the world’s largest human-derived antibody phage libraries to generate target-specific antibodies, including T cell receptor-mimic antibodies against intracellular targets.